erythromycin has been researched along with Scarlet Fever in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (65.52) | 18.7374 |
1990's | 3 (10.34) | 18.2507 |
2000's | 3 (10.34) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 4 (13.79) | 2.80 |
Authors | Studies |
---|---|
Chen, H; Gu, B; Huang, W; Lai, J; Lyu, J; Sun, L; Xiao, Y; Ye, B | 1 |
Cho, EY; Cho, HK; Cho, YN; Choi, EH; Kang, HM; Lee, H; Park, JY; Park, SE; Yun, KW | 1 |
Hu, J; Li, H; Liu, X; Ma, L; Zhao, Y; Zhou, L | 1 |
Hu, J; Li, H; Liu, X; Liu, Y; Ma, L; Qin, Q; Xu, J; Zhao, Y; Zhou, L | 1 |
HAIGHT, T | 1 |
MITOLO, GR | 1 |
Cayla, E; Chabbert, Y; Martin, L; Martin, R; Sureau, B; Veron, M | 1 |
STROM, J | 1 |
HASS, G | 1 |
COLDENBERG, E; CONTRERAS, J; GILABERT, B; HARNECKER, J; SANZ, A; UBILLA, V | 1 |
AKAO, M; HIROZUMI, S; NAKAJIMA, K; NAKAMURA, K; NAKAMURA, M; TANIGAKI, T | 1 |
BLACK, JP; CRAMBLETT, HG; MOFFETT, HL; SHULENBERGER, H; SMITH, A; WILLIAMS, AY | 1 |
Chuang, WJ; Hsu, SY; Ko, WC; Lin, MT; Lin, YS; Liu, CC; Wu, HM; Wu, JJ; Yan, JJ | 1 |
Chang, YC; Chen, YY; Chou, CY; Huang, CT; Li, SY; Shen, PW; Yao, SM | 1 |
Kist, M; Steinitz, H | 1 |
Zechner, G | 1 |
Spencer, RC | 1 |
Chiesa, C; Nanni, F; Orefici, G; Pacifico, L | 1 |
Colman, G; Efstratiou, A; Gaworzewska, ET; Tanna, A | 1 |
Avila-Figueroa, C; Bustos, IM; Espinosa de los Monteros, LE; Flores, LV | 1 |
Anania, S; Andreuzzi, A; Tosti, U; Viola, F | 1 |
Franz, C; Gladtke, E; Sorgo, W | 1 |
Hirayama, A; Misuno, K; Yoshida, R | 2 |
Hirayama, A; Iimura, I; Shimizu, H; Tomisawa, I; Yamaguchi, T | 1 |
Akiba, T; Nakamizo, Y; Sato, M; Tomizawa, I; Tsuji, M | 1 |
Ocklitz, HW; Schmidt, EF; Schmitz, HH | 1 |
Rouquès, L | 1 |
Angelescu, M; Borşai, L; CărunTUN, V; Golăescu, M; Mihalcu, F; State, D; Valeriu, A; Voiculescu, M | 1 |
1 review(s) available for erythromycin and Scarlet Fever
Article | Year |
---|---|
Invasive streptococci.
Topics: Bacteremia; Erythromycin; Global Health; Humans; Penicillins; Scarlet Fever; Shock, Septic; Skin Diseases, Bacterial; Streptococcal Infections; Streptococcus pyogenes | 1995 |
2 trial(s) available for erythromycin and Scarlet Fever
Article | Year |
---|---|
Recurrent attacks of scarlet fever.
Topics: Amoxicillin; Cefaclor; Child; Child, Preschool; Erythromycin; Female; Humans; Male; Penicillin V; Prospective Studies; Recurrence; Scarlet Fever | 1994 |
[A double-blind comparison of josamycin propionate and erythromycin ethylsuccinate in the treatment of scarlet fever with their oral suspension preparations (author's transl)].
Topics: Administration, Oral; Anti-Bacterial Agents; Child; Clinical Trials as Topic; Drug Resistance, Microbial; Erythromycin; Female; Humans; Lactones; Male; Microbial Sensitivity Tests; Scarlet Fever; Streptococcus; Suspensions; Time Factors | 1974 |
26 other study(ies) available for erythromycin and Scarlet Fever
Article | Year |
---|---|
Prevalence and identification of antibiotic-resistant scarlet fever group A Streptococcus strains in some paediatric cases at Shenzhen, China.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Carrier Proteins; Child; China; Clindamycin; Erythromycin; Humans; Microbial Sensitivity Tests; Penicillins; Prevalence; Scarlet Fever; Streptococcal Infections; Streptococcus pyogenes | 2022 |
Distribution of emm genotypes in group A streptococcus isolates of Korean children from 2012 to 2019.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Carrier Proteins; Erythromycin; Genotype; Humans; Microbial Sensitivity Tests; Republic of Korea; Scarlet Fever; Streptococcal Infections; Streptococcus pyogenes | 2022 |
Molecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in Beijing, China.
Topics: Adolescent; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Bacterial Proteins; Beijing; Cardiopulmonary Resuscitation; Carrier Proteins; Child; Child, Preschool; Drug Resistance, Bacterial; Erythromycin; Female; Hospitals, Pediatric; Humans; Infant; Male; Microbial Sensitivity Tests; Penicillins; Scarlet Fever; Streptococcus pyogenes; Superantigens | 2020 |
Epidemiological analysis of Group A Streptococcus infections in a hospital in Beijing, China.
Topics: Adolescent; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Bacterial Proteins; Beijing; Child; Child, Preschool; Drug Resistance, Bacterial; Erythromycin; Exotoxins; Female; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Male; Membrane Proteins; Microbial Sensitivity Tests; Penicillins; Scarlet Fever; Streptococcus pyogenes; Superantigens | 2020 |
Erythromycin therapy of respiratory infections. I. Controlled studies on the comparative efficacy of erythromycin and penicillin in scarlet fever.
Topics: Erythromycin; Penicillins; Research Design; Respiratory Tract Infections; Scarlet Fever | 1954 |
[Erythromycin: results in scarlet fever therapy].
Topics: Erythromycin; Humans; Scarlet Fever | 1954 |
[Results of comparative treatment of scarlatin with spiramycin and erythromycin; Difficulties in diagnosing benign forms].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Dermatologic Agents; Erythromycin; Humans; Scarlet Fever | 1955 |
Penicillin and erythromycin singly and in combination in scarlatina therapy and the interference between them.
Topics: Erythromycin; Penicillins; Scarlet Fever | 1961 |
Family chemoprophylaxis in streptococcal pharyngitis.
Topics: Chemoprevention; Erythromycin; Humans; Penicillins; Pharyngitis; Scarlet Fever; Streptococcal Infections | 1963 |
[COMMENTARIES ABOUT 16 PATIENTS WITH SCARLET FEVER TREATED WITH LINCOMYCIN. COMPARATIVE STUDY OF 5 CASES TREATED WITH ERYTHROMYCIN].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Erythromycin; Humans; Lincomycin; Scarlet Fever; Streptococcus; Toxicology | 1963 |
[RECENT PREVALENCE OF SCARLET FEVER IN OSAKA DISTRICT WITH SPECIAL REFERENCE TO EPIDEMIOLOGIC CONSIDERATIONS ON STREPTOCOCCUS HEMOLYTICUS].
Topics: Anti-Bacterial Agents; Child; Chloramphenicol; Drug Resistance, Microbial; Epidemiology; Erythromycin; Humans; Japan; Penicillin Resistance; Prevalence; Scarlet Fever; Statistics as Topic; Streptococcal Infections; Streptococcus pyogenes; Tetracycline | 1964 |
ERYTHROMYCIN ESTOLATE AND PHENOXYMETHYL PENICILLIN IN THE TREATMENT OF STREPTOCOCCAL PHARYNGITIS.
Topics: Acute Disease; Child; Drug Therapy; Erythromycin; Erythromycin Estolate; Humans; Penicillin V; Penicillins; Pharyngitis; Scarlet Fever; Streptococcal Infections | 1963 |
Molecular analysis of group A streptococcal isolates associated with scarlet fever in southern Taiwan between 1993 and 2002.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Typing Techniques; Carrier Proteins; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Scarlet Fever; Streptococcal Infections; Streptococcus pyogenes; Taiwan | 2003 |
Molecular epidemiology of group A streptococcus causing scarlet fever in northern Taiwan, 2001-2002.
Topics: Adolescent; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Carrier Proteins; Child; Child, Preschool; Chloramphenicol; Clindamycin; Cluster Analysis; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Humans; Infant; Microbial Sensitivity Tests; Molecular Epidemiology; Scarlet Fever; Sequence Analysis, DNA; Streptococcus; Streptococcus pyogenes; Taiwan | 2007 |
[Diagnostic, therapeutic and hygienic measures in epidemic scarlet fever].
Topics: Carrier State; Child; Communicable Disease Control; Community Health Services; Disease Outbreaks; Disinfection; Erythromycin; Humans; Penicillins; Scarlet Fever; School Health Services | 1982 |
[The value of targeted antibiotic therapy based on the example of streptococcal infections with special reference to late side effects].
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Erysipelas; Erythromycin; Humans; Penicillin Resistance; Penicillins; Pharyngitis; Scarlet Fever; Streptococcal Infections; Time Factors | 1983 |
The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their association with disease.
Topics: Bacteremia; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Erythromycin; Female; Glomerulonephritis; Humans; Male; Meningitis, Bacterial; Nasal Mucosa; Occupational Diseases; Otitis Media; Pharyngitis; Psoriasis; Puerperal Infection; Rheumatic Fever; Scarlet Fever; Serotyping; Skin Diseases, Bacterial; Streptococcal Infections; Streptococcus pyogenes; United Kingdom; Virulence; Vulvovaginitis | 1993 |
Outbreak of scarlet fever caused by an erythromycin-resistant Streptococcus pyogenes emm22 genotype strain in a day-care center.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Child Day Care Centers; Child, Preschool; Disease Outbreaks; Drug Resistance, Bacterial; Erythromycin; Genotype; Humans; Infant; Membrane Proteins; Mexico; Scarlet Fever; Streptococcus pyogenes | 2001 |
[Current clinical aspects of scarlet fever and its treatment with antibiotics].
Topics: Adolescent; Bronchopneumonia; Child; Child, Preschool; Erythromycin; Female; Humans; Infant; Male; Nephritis; Penicillin G; Rheumatic Diseases; Scarlet Fever | 1978 |
[Diphtheria].
Topics: Ampicillin; Carrier State; Corynebacterium diphtheriae; Diphtheria; Diphtheria Toxoid; Erythromycin; Humans; Immunity; Oxacillin; Penicillins; Scarlet Fever; Tetracycline; Virulence | 1977 |
[Decrease in tetracycline-resistant strains and changes in type distribution of Group A hemolytic streptococci recently isolated from patients with scarlet fever].
Topics: Chloramphenicol; Drug Resistance, Microbial; Erythromycin; Humans; Scarlet Fever; Streptococcus pyogenes; Tetracycline | 1976 |
[Antibiotic therapy of scarlet fever].
Topics: Adolescent; Anti-Bacterial Agents; Cephalexin; Child; Child, Preschool; Clindamycin; Erythromycin; Humans; Scarlet Fever | 1973 |
[Drug sensitivity of Streptococcus haemolyticus ecently isolated from patients with scarlet fever with special reference to the advent of an erythromycin-resistant strain].
Topics: Drug Resistance, Microbial; Erythromycin; Humans; Scarlet Fever; Streptococcus | 1972 |
[Pediatric guidelines. 3. Antibiotics--indications].
Topics: Anti-Bacterial Agents; Bronchitis; Child; Chloramphenicol; Diphtheria; Erythromycin; Humans; Infection Control; Infections; Influenza, Human; Measles; Penicillins; Pneumonia; Scarlet Fever; Sulfonamides; Tetracycline; Tonsillitis; Whooping Cough | 1968 |
[Scarlet fever in 1968].
Topics: Communicable Disease Control; Erythromycin; Humans; Leukocytosis; Mastoiditis; Nephritis; Penicillins; Rheumatic Diseases; Scarlet Fever; Skin Manifestations; Streptococcus; Tonsillitis; Urobilin | 1968 |
[Sensitivity of beta-hemolytic streptococcus, group A, isolated from streptococcal infections, to different antibiotics and sulfonamides].
Topics: Chloramphenicol; Erythromycin; Humans; Penicillins; Scarlet Fever; Streptococcus; Sulfonamides; Tetracycline; Tonsillitis | 1967 |